Royce & Associates »

C4 Therapeutics shares owned by Royce & Associates

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Royce & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $240k 43k 5.65